Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Cytoplasmic deposition of NFκB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation

Abstract

Lung inflammation leads to severe tissue destruction and ultimately organ failure in a number of diseases, including cystic fibrosis (CF). The transcription factor nuclear factor kappa B (NFκB) regulates expression of many pro-inflammatory mediators. We have assessed the effect of topical administration of NFκB decoys in a bleomycin model of acute lung inflammation. Using fluorescein-labelled decoy oligonucleotides (ODN) (80 μg/mouse) we have shown that lipid-complexed and ‘naked’ ODN transfect conducting airway epithelium in a comparable manner (approximately 65% of cells). However, the ODN were detectable in the cytoplasm, but not in the nucleus of transfected cells. An increase of ODN dose to 500 μg/mouse did not increase nuclear transfection significantly. We determined the effect of cytoplasmic NFκB decoys on bleomycin-induced inflammation. We transfected mice with ‘naked’ decoy and scrambled ODN (500 μg) 1 h before intratracheal administration of bleomycin. We measured IL6 secretion in BALF and lung homogenates and total and differential cell counts in BALF 5 days after bleomycin administration. We did not detect a difference between NFκB decoy and scrambled ODN-treated animals in any of the parameters tested. We suggest that access of ODN to the nucleus of airway epithelial cells is a key problem, limiting the efficacy of such decoy strategies, as well as attempts at gene repair.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Fan J, Ye RD, Malik AB . Transcriptional mechanisms of acute lung injury Am J Physiol Lung Cell Mol Physiol 2001 281: L1037–L1050

    Article  CAS  Google Scholar 

  2. Oermann CM . Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future Curr Opin Invest Drugs 2001 2: 900–906

    CAS  Google Scholar 

  3. Pantelidis P et al. Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 2001 163: 1432–1436

    Article  CAS  Google Scholar 

  4. Pantelidis P et al. Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis Thrall RS, Scalise RJ. Bleomycin. In: Thrall RS (ed.). Pulmonary Fibrosis. Marcel Dekker, New York, 1984, pp 50–75.

  5. Piguet PF, Vesin C . Pulmonary platelet trapping induced by bleomycin: correlation with fibrosis and involvement of the beta 2 integrins Int J Exp Pathol 1994 75: 321–328

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Scheule RK, Perkins RC, Hamilton R, Holian A . Bleomycin stimulation of cytokine secretion by the human alveolar macrophage Am J Physiol 1992 262: L386–L391

    CAS  PubMed  Google Scholar 

  7. Baeuerle PA, Henkel T . Function and activation of NF-kappa B in the immune system Annu Rev Immunol 1994 12: 141–179

    Article  CAS  Google Scholar 

  8. Gurujeyalakshmi G, Wang Y, Giri SN . Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice J Pharmacol Exp Ther 2000 293: 82–90

    CAS  PubMed  Google Scholar 

  9. Caspary WJ, Lanzo DA, Niziak C . Effect of deoxyribonucleic acid on the production of reduced oxygen by bleomycin and iron Biochemistry 1982 21: 334–338

    Article  CAS  Google Scholar 

  10. Lentsch AB, Shanley TP, Sarma V, Ward PA . In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13 J Clin Invest 1997 100: 2443–2448

    Article  CAS  Google Scholar 

  11. Raychaudhuri B et al. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages Cytokine 2000 12: 1348–1355

    Article  CAS  Google Scholar 

  12. Van Der Saag PT, Caldenhoven E, van de SA . Molecular mechanisms of steroid action: a novel type of cross-talk between glucocorticoids and NF-kappa B transcription factors Eur Respir J Suppl 1996 22: 146–153

    Google Scholar 

  13. D'Acquisto F et al. Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw Gene Therapy 2000 7: 1731–1737

    Article  CAS  Google Scholar 

  14. Suzuki J et al. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts Gene Therapy 2000 7: 1847–1852

    Article  CAS  Google Scholar 

  15. Tomita N et al. Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo Gene Therapy 2000 7: 1326–1332

    Article  CAS  Google Scholar 

  16. Griesenbach U et al. Anti-inflammatory gene therapy directed at the airway epithelium Gene Therapy 2000 7: 306–313

    Article  CAS  Google Scholar 

  17. Neurath MF et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice Nat Med 1996 2: 998–1004

    Article  CAS  Google Scholar 

  18. Zhang XY et al. Antisense oligonucleotides to NF-kappaB improve survival in bleomycin-induced pneumopathy of the mouse Am J Respir Crit Care Med 2000 162: 1561–1568

    Article  CAS  Google Scholar 

  19. Feldherr CM, Kallenbach E, Schultz N . Movement of a karyophilic protein through the nuclear pores of oocytes J Cell Biol 1984 99: 2216–2222

    Article  CAS  Google Scholar 

  20. Kren BT, Bandyopadhyay P, Steer CJ . In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides Nat Med 1998 4: 285–290

    Article  CAS  Google Scholar 

  21. Kren BT et al. Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotide Proc Natl Acad Sci USA 1999 96: 10349–10354

    Article  CAS  Google Scholar 

  22. Collas P, Alestrom P . Nuclear localization signals enhance germline transmission of a transgene in zebrafish Transgenic Res 1998 7: 303–309

    Article  CAS  Google Scholar 

  23. Ludtke JJ, Zhang G, Sebestyen MG, Wolff JA . A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA J Cell Sci 1999 112: 2033–2041

    CAS  Google Scholar 

  24. Zanta MA, Belguise-Valladier P, Behr JP . Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus Proc Natl Acad Sci USA 1999 96: 91–96

    Article  CAS  Google Scholar 

  25. Geary RS et al. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression Drug Metab Dispos 1997 25: 1272–1281

    CAS  PubMed  Google Scholar 

  26. Sausville EA, Stein RW, Peisach J, Horwitz SB . Properties and products of the degradation of DNA by bleomycin and iron(II) Biochemistry 1978 17: 2746–2754

    Article  CAS  Google Scholar 

  27. Ortiz LA et al. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice Exp Lung Res 1998 24: 721–743

    Article  CAS  Google Scholar 

  28. Smith RE et al. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury J Leukoc Biol 1998 64: 528–536

    Article  CAS  Google Scholar 

  29. Karmiol S, Remick DG, Kunkel SL, Phan SH . Regulation of rat pulmonary endothelial cell interleukin-6 production by bleomycin: effects of cellular fatty acid composition Am J Respir Cell Mol Biol 1993 9: 628–636

    Article  CAS  Google Scholar 

  30. Gosset P et al. Production of chemokines and proinflammatory and antiinflammatory cytokines by human alveolar macrophages activated by IgE receptors J Allergy Clin Immunol 1999 103: 289–297

    Article  CAS  Google Scholar 

  31. Martin LD et al. Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators Eur Respir J 1997 10: 2139–2146

    Article  CAS  Google Scholar 

  32. Van den Berghe W et al. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6 Biochem Pharmacol 2000 60: 1185–1195

    Article  CAS  Google Scholar 

  33. Simeonova PP et al. Molecular regulation of IL-6 activation by asbestos in lung epithelial cells: role of reactive oxygen species J Immunol 1997 159: 3921–3928

    CAS  PubMed  Google Scholar 

  34. Beetz A et al. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells Int J Radiat Biol 2000 76: 1443–1453

    Article  CAS  Google Scholar 

  35. Keane MP et al. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis J Immunol 1999 162: 5511–5518

    CAS  PubMed  Google Scholar 

  36. Driscoll KE et al. Crocidolite activates NF-kappa B and MIP-2 gene expression in rat alveolar epithelial cells. Role of mitochondrial-derived oxidants Environ Health Perspect 1998 106: 1171–1174

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Crestani B et al. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products J Clin Invest 1994 94: 731–740

    Article  CAS  Google Scholar 

  38. Cromwell O et al. Expression and generation of interleukin-8, IL-6 and granulocyte–macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumor necrosis factor-alpha Immunology 1992 77: 330–337

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Losa Garcia JE et al. Evaluation of inflammatory cytokine secretion by human alveolar macrophages Mediators Inflamm 1999 8: 43–51

    Article  CAS  Google Scholar 

  40. Tomita N et al. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells J Hypertens 1998 16: 993–1000

    Article  Google Scholar 

  41. Schrier DJ, Kunkel RG, Phan SH . The role of strain variation in murine bleomycin-induced pulmonary fibrosis Am Rev Respir Dis 1983 127: 63–66

    Article  CAS  Google Scholar 

  42. Papaioannou VE, Fox JG . Efficacy of tribromoethanol anesthesia in mice Lab Anim Sci 1993 43: 189–192

    CAS  Google Scholar 

  43. Lee ER et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung Hum Gene Ther 1996 7: 1701–1717

    Article  CAS  Google Scholar 

  44. Peterson GL . A simplification of the protein assay method of Lowry et al, which is more generally applicable Anal Biochem 1977 83: 346–356

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Naruya Tomita (Osaka University Medical School, Japan) for help in designing the NFκB decoy ODN, Dr Seng Cheng (Genzyme) for providing the lipid GL67 and Mr Ben Booy and Mr Steve Rothery (Confocal Microscopy Unit, Royal Brompton Hospital, London, UK) for help with the confocal analysis. This research was funded by the Cystic Fibrosis Research Trust and a Wellcome Trust Senior Clinical Fellowship (EWFWA).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Griesenbach, U., Cassady, R., Cain, R. et al. Cytoplasmic deposition of NFκB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation. Gene Ther 9, 1109–1115 (2002). https://doi.org/10.1038/sj.gt.3301776

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301776

Keywords

Search

Quick links